Suter U - Search Results

1

Phosphoinositides and Charcot-Marie-tooth disease: new keys to old questions.

Suter U. Suter U. Cell Mol Life Sci. 2007 Dec;64(24):3261-5. doi: 10.1007/s00018-007-7381-7. Cell Mol Life Sci. 2007. PMID: 17965826 Free PMC article. Review.

2

Genetic basis of inherited peripheral neuropathies.

Suter U, Patel PI. Suter U, et al. Hum Mutat. 1994;3(2):95-102. doi: 10.1002/humu.1380030203. Hum Mutat. 1994. PMID: 7515304 Review.

3

Peripheral myelin protein 22: facts and hypotheses.

Suter U, Snipes GJ. Suter U, et al. J Neurosci Res. 1995 Feb 1;40(2):145-51. doi: 10.1002/jnr.490400202. J Neurosci Res. 1995. PMID: 7745607 Review.

4

Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy.

Adlkofer K, Frei R, Neuberg DH, Zielasek J, Toyka KV, Suter U. Adlkofer K, et al. Among authors: suter u. J Neurosci. 1997 Jun 15;17(12):4662-71. doi: 10.1523/JNEUROSCI.17-12-04662.1997. J Neurosci. 1997. PMID: 9169527 Free PMC article.

5

PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.

Colby J, Nicholson R, Dickson KM, Orfali W, Naef R, Suter U, Snipes GJ. Colby J, et al. Among authors: suter u. Neurobiol Dis. 2000 Dec;7(6 Pt B):561-73. doi: 10.1006/nbdi.2000.0323. Neurobiol Dis. 2000. PMID: 11114256

6

Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.

Sancho S, Young P, Suter U. Sancho S, et al. Among authors: suter u. Brain. 2001 Nov;124(Pt 11):2177-87. doi: 10.1093/brain/124.11.2177. Brain. 2001. PMID: 11673320

7

Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease.

Young P, Suter U. Young P, et al. Among authors: suter u. Brain Res Brain Res Rev. 2001 Oct;36(2-3):213-21. doi: 10.1016/s0165-0173(01)00097-2. Brain Res Brain Res Rev. 2001. PMID: 11690618 Review.

8

Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.

Atanasoski S, Scherer SS, Nave KA, Suter U. Atanasoski S, et al. Among authors: suter u. J Neurosci Res. 2002 Feb 15;67(4):443-9. doi: 10.1002/jnr.10133. J Neurosci Res. 2002. PMID: 11835311

9

Molecular cell biology of Charcot-Marie-Tooth disease.

Berger P, Young P, Suter U. Berger P, et al. Among authors: suter u. Neurogenetics. 2002 Mar;4(1):1-15. doi: 10.1007/s10048-002-0130-z. Neurogenetics. 2002. PMID: 12030326 Review.

10

Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1.

Berger P, Bonneick S, Willi S, Wymann M, Suter U. Berger P, et al. Among authors: suter u. Hum Mol Genet. 2002 Jun 15;11(13):1569-79. doi: 10.1093/hmg/11.13.1569. Hum Mol Genet. 2002. PMID: 12045210

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters